AUG 19, 2026 · PHASE EARLY PHASE 1 TRIAL
Recombinant Human Serum Albumin in the Treatment of AD (Alzheimer Disease) Exploratory Clinical Trials
ClinicalTrials.gov
Early-phase exploratory study with safety as primary outcome; no efficacy results reported in this registry record.
Reported
Planned enrollment30
PhaseEARLY_PHASE1
Primary outcome measureAdverse Events